Impact of Intravascular Brachytherapy on Patient-Reported Outcomes in Patients with Coronary Artery Disease
Sahil Rawal1, Abhishek C Sawant1, Meenakshi Sridhar1
1University Medical Center, Phoenix, AZ, USA.
Insights
Intravascular brachytherapy (VBT) significantly improves patient-reported outcomes for in-stent restenosis. Quality of life, angina frequency, and activity levels showed sustained improvement post-treatment.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Radiation Oncology
Background:
- Intravascular brachytherapy (VBT) is an established treatment for in-stent restenosis (ISR).
- Patient-reported outcomes (PROs) following VBT for ISR remain incompletely understood.
- This study investigates the impact of VBT on PROs in patients with ISR.
Purpose of the Study:
- To evaluate the effect of VBT on patient-reported outcomes in managing in-stent restenosis.
- To assess changes in quality of life, angina frequency, and physical activity following VBT.
Main Methods:
- A cohort of 51 patients undergoing VBT for coronary ISR between January 2018 and September 2019 was analyzed.
- Data collected included baseline characteristics, procedural outcomes, and adverse events.
- Patients completed the Seattle Angina Questionnaire-7 (SAQ-7) at baseline, 1 month, and 6 months post-VBT.
Main Results:
- The mean SAQ-7 summary score significantly improved from 53.2 to 83 at 30 days (p < .001), with sustained improvement at long-term follow-up.
- Significant improvements were observed in Quality of Life (QoL) and angina frequency components of the SAQ-7.
- Activity limitations also showed significant improvement, with results evident at 1 month and sustained up to a median follow-up of 17 months.
Conclusions:
- VBT is associated with significant improvements in patient-reported outcomes for in-stent restenosis.
- These improvements in quality of life and symptom burden are observed early and sustained over time.
- VBT represents an effective treatment option for enhancing patient well-being in ISR management.
Background:
Intravascular brachytherapy (VBT) is an established treatment for the management of in-stent restenosis (ISR). However, whether VBT is associated with improved patient reported outcomes unknown.
Methods:
We evaluated 51 consecutive patients undergoing VBT in one or more coronary arteries from January 2018 to September 2019. Data on baseline characteristics, procedural outcomes and adverse events were obtained. All patients completed the Seattle Angina Questionnaire - 7 (SAQ-7) form before and after VBT at 1 month and 6 months.
Results:
The mean age was 69 ± 9 years and 29 (57%) of patients were males. Procedural success was 94.1%. The mean summary SAQ-7 score improved significantly (53.2 ± 21 vs. 83 ± 19, p < .001) at 30-days. The median Quality of Life (QoL) component of SAQ-7 score was 31.3 (Interquartile Range [IQR]: 18.8, 62.5) and improved to 82.5 (IQR: 62.5, 100), p < .001 at 30 days and 87.5 [IQR: 75, 100), p < .001 at last follow up. Likewise, the median angina frequency component of the SQL-7 score pre-VBT was 55 (IQR: 45, 80) and improved significantly to 90 (IQR: 60, 100) at 30-days, p < .001 and 100 [IQR: 68.8, 100], p = .02 at last follow up. Lastly, the median activity component of the SAQ-7 score improved from 83.3 (IQR: 60-100) to 100 (IQR: 83, 100), p = .01 at 30-days. Thus, results were evident as early as 1 month and sustained at median follow up of 17 months.
Conclusion:
VBT is associated with improvement in patient reported outcome measures at short term and long term follow up.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease IV: Nursing Management
Coronary Artery Disease III: Clinical Manifestations


